The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T

Pierluigi Di Giovanni, C. A. Azlan, Trevor Sean Ahearn, Scott Ian Kay Semple, Fiona Jane Gilbert, Thomas William Redpath

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The purpose of this work is to quantify the accuracy of pharmacokinetic parameter measurement in DCE-MRI of breast cancer at 3 T in relation to three sources of error. Individually, T1 measurement error, temporal resolution and transmitted RF field inhomogeneity are considered. Dynamic contrast enhancement curves were simulated using standard acquisition parameters of a DCE-MRI protocol. Errors on pre-contrast T1 due to incorrect RF spoiling were considered. Flip angle errors were measured and introduced into the fitting routine, and temporal resolution was also varied. The error in fitted pharmacokinetic parameters, K-trans and v(e), was calculated. Flip angles were found to be reduced by up to 55% of the expected value. The resultant errors in our range of K-trans and v(e) were found to be up to 66% and 74%, respectively. Incorrect T1 estimation results in K-trans and v(e) errors up to 531% and 233%, respectively. When the temporal resolution is reduced from 10 to 70 s K-trans drops by up to 48%, while v(e) shows negligible variation. In combination, uncertainties in tissue T1 map and applied flip angle were shown to contribute to errors of up to 88% in K-trans and 73% in v(e). These results demonstrate the importance of high temporal resolution, accurate T1 measurement and good B1 homogeneity.

Original languageEnglish
Pages (from-to)121-132
Number of pages12
JournalPhysics in Medicine and Biology
Volume55
Issue number1
DOIs
Publication statusPublished - 7 Jan 2010

Keywords

  • contrast-enhanced MRI
  • temporal sampling requirements
  • tracer kinetics
  • cancer
  • tumors
  • chemotherapy
  • permeability
  • sequences
  • volume

Cite this

The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T. / Di Giovanni, Pierluigi; Azlan, C. A.; Ahearn, Trevor Sean; Semple, Scott Ian Kay; Gilbert, Fiona Jane; Redpath, Thomas William.

In: Physics in Medicine and Biology, Vol. 55, No. 1, 07.01.2010, p. 121-132.

Research output: Contribution to journalArticle

Di Giovanni, Pierluigi ; Azlan, C. A. ; Ahearn, Trevor Sean ; Semple, Scott Ian Kay ; Gilbert, Fiona Jane ; Redpath, Thomas William. / The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T. In: Physics in Medicine and Biology. 2010 ; Vol. 55, No. 1. pp. 121-132.
@article{d313639406294454964502bca958a52f,
title = "The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T",
abstract = "The purpose of this work is to quantify the accuracy of pharmacokinetic parameter measurement in DCE-MRI of breast cancer at 3 T in relation to three sources of error. Individually, T1 measurement error, temporal resolution and transmitted RF field inhomogeneity are considered. Dynamic contrast enhancement curves were simulated using standard acquisition parameters of a DCE-MRI protocol. Errors on pre-contrast T1 due to incorrect RF spoiling were considered. Flip angle errors were measured and introduced into the fitting routine, and temporal resolution was also varied. The error in fitted pharmacokinetic parameters, K-trans and v(e), was calculated. Flip angles were found to be reduced by up to 55{\%} of the expected value. The resultant errors in our range of K-trans and v(e) were found to be up to 66{\%} and 74{\%}, respectively. Incorrect T1 estimation results in K-trans and v(e) errors up to 531{\%} and 233{\%}, respectively. When the temporal resolution is reduced from 10 to 70 s K-trans drops by up to 48{\%}, while v(e) shows negligible variation. In combination, uncertainties in tissue T1 map and applied flip angle were shown to contribute to errors of up to 88{\%} in K-trans and 73{\%} in v(e). These results demonstrate the importance of high temporal resolution, accurate T1 measurement and good B1 homogeneity.",
keywords = "contrast-enhanced MRI, temporal sampling requirements, tracer kinetics, cancer, tumors, chemotherapy, permeability, sequences, volume",
author = "{Di Giovanni}, Pierluigi and Azlan, {C. A.} and Ahearn, {Trevor Sean} and Semple, {Scott Ian Kay} and Gilbert, {Fiona Jane} and Redpath, {Thomas William}",
year = "2010",
month = "1",
day = "7",
doi = "10.1088/0031-9155/55/1/008",
language = "English",
volume = "55",
pages = "121--132",
journal = "Physics in Medicine and Biology",
issn = "0031-9155",
publisher = "IOP Publishing Ltd.",
number = "1",

}

TY - JOUR

T1 - The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T

AU - Di Giovanni, Pierluigi

AU - Azlan, C. A.

AU - Ahearn, Trevor Sean

AU - Semple, Scott Ian Kay

AU - Gilbert, Fiona Jane

AU - Redpath, Thomas William

PY - 2010/1/7

Y1 - 2010/1/7

N2 - The purpose of this work is to quantify the accuracy of pharmacokinetic parameter measurement in DCE-MRI of breast cancer at 3 T in relation to three sources of error. Individually, T1 measurement error, temporal resolution and transmitted RF field inhomogeneity are considered. Dynamic contrast enhancement curves were simulated using standard acquisition parameters of a DCE-MRI protocol. Errors on pre-contrast T1 due to incorrect RF spoiling were considered. Flip angle errors were measured and introduced into the fitting routine, and temporal resolution was also varied. The error in fitted pharmacokinetic parameters, K-trans and v(e), was calculated. Flip angles were found to be reduced by up to 55% of the expected value. The resultant errors in our range of K-trans and v(e) were found to be up to 66% and 74%, respectively. Incorrect T1 estimation results in K-trans and v(e) errors up to 531% and 233%, respectively. When the temporal resolution is reduced from 10 to 70 s K-trans drops by up to 48%, while v(e) shows negligible variation. In combination, uncertainties in tissue T1 map and applied flip angle were shown to contribute to errors of up to 88% in K-trans and 73% in v(e). These results demonstrate the importance of high temporal resolution, accurate T1 measurement and good B1 homogeneity.

AB - The purpose of this work is to quantify the accuracy of pharmacokinetic parameter measurement in DCE-MRI of breast cancer at 3 T in relation to three sources of error. Individually, T1 measurement error, temporal resolution and transmitted RF field inhomogeneity are considered. Dynamic contrast enhancement curves were simulated using standard acquisition parameters of a DCE-MRI protocol. Errors on pre-contrast T1 due to incorrect RF spoiling were considered. Flip angle errors were measured and introduced into the fitting routine, and temporal resolution was also varied. The error in fitted pharmacokinetic parameters, K-trans and v(e), was calculated. Flip angles were found to be reduced by up to 55% of the expected value. The resultant errors in our range of K-trans and v(e) were found to be up to 66% and 74%, respectively. Incorrect T1 estimation results in K-trans and v(e) errors up to 531% and 233%, respectively. When the temporal resolution is reduced from 10 to 70 s K-trans drops by up to 48%, while v(e) shows negligible variation. In combination, uncertainties in tissue T1 map and applied flip angle were shown to contribute to errors of up to 88% in K-trans and 73% in v(e). These results demonstrate the importance of high temporal resolution, accurate T1 measurement and good B1 homogeneity.

KW - contrast-enhanced MRI

KW - temporal sampling requirements

KW - tracer kinetics

KW - cancer

KW - tumors

KW - chemotherapy

KW - permeability

KW - sequences

KW - volume

U2 - 10.1088/0031-9155/55/1/008

DO - 10.1088/0031-9155/55/1/008

M3 - Article

VL - 55

SP - 121

EP - 132

JO - Physics in Medicine and Biology

JF - Physics in Medicine and Biology

SN - 0031-9155

IS - 1

ER -